• 10074-G5: Benchmark c-Myc Inhibitor for Translational Cancer

  2026-07-21

  10074-G5 is a validated small-molecule c-Myc inhibitor that disrupts c-Myc/Max dimerization, enabling robust cell cycle arrest and apoptosis in cancer models. Quantitative in vitro and in vivo benchmarks support its use in translational oncology workflows.

• AMG 9810: Bridging TRPV1 Antagonism with Metabolic Stress In

  2026-07-21

  This thought-leadership article dissects the evolving landscape of TRPV1 antagonism, with a spotlight on AMG 9810 as a translational tool. Integrating mechanistic insights from recent metabolic stress research, we provide actionable guidance for researchers seeking to unravel pain and sensory neuron signaling. The piece uniquely bridges the AMPK–SQSTM1 feedback axis and TRPV1-mediated nociception, offering protocol strategies and a forward-looking perspective for innovative pain mechanism studies.

• Ionomycin Free Acid: Selective Calcium Ionophore in Cell Sig

  2026-07-20

  Ionomycin free acid is a highly selective calcium ionophore used to increase intracellular calcium concentrations in research applications. This reagent enables precise manipulation of calcium signaling, essential for studies in cancer biology and embryonic development. Reliable protocols and product specifications are provided by APExBIO.

• Serine/Glycine-Free Diet: Dual Effects on CRC Immunity and P

  2026-07-20

  This study demonstrates that a serine/glycine-free diet both inhibits colorectal cancer growth and enhances antitumor immune responses, while paradoxically promoting immune evasion via PD-L1 lactylation in tumor cells. The findings highlight a metabolic-immune axis that may guide more effective combination immunotherapies and dietary interventions.

• EdU Flow Cytometry Assay Kits (Cy5): Precision in S-Phase De

  2026-07-19

  EdU Flow Cytometry Assay Kits (Cy5) bring unparalleled sensitivity and multiplexing flexibility to S-phase DNA synthesis detection, outperforming traditional BrdU-based methods. Their streamlined workflow and compatibility with immune and cell cycle profiling make them indispensable for high-throughput cancer and pharmacodynamic research.

• Foretinib (GSK1363089) in Advanced Tumor Growth Inhibition M

  2026-07-18

  Foretinib (GSK1363089) stands out as a potent multikinase inhibitor, validated for suppressing tumor proliferation and metastasis in diverse cancer models. This article distills data-driven workflows, troubleshooting strategies, and applied findings to help oncology researchers maximize Foretinib's translational value.

• EP4 Deficiency in Macrophages Accelerates Atherosclerosis vi

  2026-07-17

  Tang et al. (2025) reveal that loss of the prostaglandin E2 receptor EP4 in macrophages intensifies atherosclerosis by promoting CD36-driven lipid uptake and M1 polarization. This mechanistic insight helps refine strategies for studying plaque progression and designing targeted interventions.

• U0126: Empowering Translational Breakthroughs via MEK1/2 Inh

  2026-07-17

  Explore how U0126, a selective MEK1/2 inhibitor, is advancing translational research by enabling precise MAPK/ERK pathway inhibition. This article provides mechanistic insight, strategic experimental guidance, and a forward-looking perspective for researchers in cancer biology, neurobiology, and pain signaling, referencing recent evidence on orofacial inflammatory allodynia and the emerging landscape of MEK-targeted approaches.

• Direct Mouse Genotyping Kit Plus: Rapid PCR for Mouse Assays

  2026-07-16

  The Direct Mouse Genotyping Kit Plus empowers researchers to streamline animal colony screening and genetic validation with fast, purification-free workflows. Leveraging an integrated PCR master mix with dye reagents, this kit minimizes hands-on time while maximizing fidelity and reproducibility, especially in advanced lineage-tracing and phenotypic studies.

• Dinaciclib (SCH727965): CDK Inhibition and Tissue Boundary D

  2026-07-16

  Explore how Dinaciclib (SCH727965) enables precision cancer research by targeting cyclin-dependent kinases and influencing tissue boundary maintenance. This article uniquely connects CDK inhibition with novel insights into tissue compartmentalization.

• EdU Flow Cytometry Assay Kits (Cy5): Precision DNA Synthesis

  2026-07-15

  EdU Flow Cytometry Assay Kits (Cy5) empower researchers with direct, multiplexable S-phase DNA synthesis detection via click chemistry, surpassing traditional BrdU assays. Optimized for sensitive cell proliferation analysis, these kits streamline experimental workflows in cancer research, regenerative medicine, and biomarker validation.

• Vancomycin: Mechanistic Power and Strategic Leverage in Resi

  2026-07-15

  This thought-leadership article explores Vancomycin’s mechanistic foundation as a glycopeptide antibiotic and delivers actionable guidance for translational researchers confronting bacterial resistance. By integrating recent comparative evidence, competitive insights, and advanced workflow considerations, this piece empowers investigators to deploy Vancomycin with precision in studies of MRSA, Clostridium difficile, and cell wall-targeting resistance. The article distinctly advances beyond standard product guides, offering a nuanced synthesis of biological rationale, experimental design, and translational implications.

• Synthetic Lethality by Epigenetic Mcl-1 and BCL-XL Inhibitio

  2026-07-14

  This study demonstrates that epigenetic suppression of Mcl-1, combined with pharmacological inhibition of BCL-XL/BCL-2, induces synthetic lethality in glioblastoma models. The approach disrupts apoptotic resistance mechanisms, highlighting a promising therapeutic strategy for difficult-to-treat brain tumors.

• GA/PPC-Modified Lipid Nanoparticles for siRNA Liver Therapy

  2026-07-14

  This study demonstrates that incorporating glycyrrhizic acid and polyene phosphatidylcholine into lipid nanoparticles significantly enhances the delivery and gene-silencing efficiency of p65 siRNA in models of acute liver injury. The findings indicate these modified nanoparticles reduce cytotoxicity, improve nucleic acid stability, and provide a promising non-viral approach for hepatic gene therapy.

• Prestained Protein Marker: Precision Tools for Ribotoxic Str

  2026-07-13

  Explore how the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) empowers protein scientists to dissect ribotoxic stress signaling and UV-induced apoptosis with unmatched clarity. This cornerstone article offers a mechanistic deep dive and practical guidance for advanced SDS-PAGE and Western blot workflows.

16084 records 1/1073 page Next 12345 下5页 Last page